Who Supplies Montelukast? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Montelukast exports, with 510+ registered manufacturers shipping to buyers across 138+ countries — yet a handful of companies dominate the shipments. MACLEODS PHARMACEUTICALS LTD holds the largest share at 36.4% (export value: $61.3M). Close behind, UNICHEM LABORATORIES LIMITED (5.2%, $8.8M). AJANTA PHARMA LIMITED (4.7%, $8.0M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Montelukast? Top Manufacturers & Their Buyers
Flow of Montelukast from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Montelukast Supplier Network — Key Market Intelligence
The Montelukast export market from India is led by MACLEODS PHARMACEUTICALS LTD, which alone commands a 36.4% share, shipping $61.3M worth of product across 231 shipments. The second-largest exporter, UNICHEM LABORATORIES LIMITED, contributes $8.8M (5.2%) to the overall market. Combined, the top two suppliers alone account for 41.7% of all Montelukast exports, indicating a relatively concentrated supply base.
Across all 510 tracked manufacturers, the total Montelukast export value stands at $168.3M from 6.4K shipments. The market average shipment value is $26.2K. The single largest buyer relationship in terms of trade value is AMERISOURCE HEALTH SERVICES, receiving $28.4M worth of product.
The combined buyer network spans 21 named purchasing companies, including AMERISOURCE HEALTH SERVICES, MACLEODS PHARMA USA ,INC, MACLEODS PHARMACEUTI, UNICHEM PHARMACEUTICALS (USA) INC, THE CATHAY DRUG CO INC and 16 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the first-largest Montelukast exporter from India, with a market share of 36.4% and a total export value of $61.3M across 231 shipments. Their average shipment value of $265.4K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• AMERISOURCE HEALTH SERVICES — $28.4M across 107 shipments (46.4% of this supplier's total exports)
• MACLEODS PHARMA USA ,INC — $25.1M across 94 shipments (40.9% of this supplier's total exports)
• AMERISOURCE HEALTH SERVICES — $7.3M across 28 shipments (11.9% of this supplier's total exports)
• MACLEODS PHARMACEUTI — $273.9K across 1 shipments (0.4% of this supplier's total exports)
• MACLEODS PHARMA USA ,INC — $214.2K across 1 shipments (0.3% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $265.4K is 914% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
2UNICHEM LABORATORIES LIMITED
UNICHEM LABORATORIES LIMITED is the second-largest Montelukast exporter from India, with a market share of 5.2% and a total export value of $8.8M across 262 shipments. Their average shipment value of $33.7K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
UNICHEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• UNICHEM PHARMACEUTICALS (USA) INC — $3.0M across 89 shipments (34.1% of this supplier's total exports)
• UNICHEM PHARMACEUTICALS (USA) INC — $2.9M across 86 shipments (32.9% of this supplier's total exports)
• UNICHEM PHARMACEUTICALS (USA) INC — $2.2M across 65 shipments (24.6% of this supplier's total exports)
• UNICHEM PHARMACEUTICALS (USA) INC — $582.3K across 17 shipments (6.6% of this supplier's total exports)
• UNICHEM PHARMACEUTICALS (USA) INC — $155.8K across 5 shipments (1.8% of this supplier's total exports)
Key Insight: UNICHEM LABORATORIES LIMITED's per-shipment value of $33.7K is 29% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
3AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the third-largest Montelukast exporter from India, with a market share of 4.7% and a total export value of $8.0M across 128 shipments. Their average shipment value of $62.2K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• THE CATHAY DRUG CO INC — $2.6M across 41 shipments (32.1% of this supplier's total exports)
• AJANTA PHARMA PHILIPPINES INC — $2.3M across 38 shipments (29.4% of this supplier's total exports)
• THE CATHAY DRUG CO. INC — $1.3M across 20 shipments (15.9% of this supplier's total exports)
• THE CATHAY DRUG CO INC — $1.3M across 20 shipments (15.9% of this supplier's total exports)
• SHAMS AL-THURAYA CO — $523.8K across 8 shipments (6.6% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $62.2K is 138% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
4CIPLA LIMITED
CIPLA LIMITED is the fourth-largest Montelukast exporter from India, with a market share of 4.4% and a total export value of $7.4M across 92 shipments. Their average shipment value of $80.4K is above the market average of $26.2K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. BREATHEFREE LANKA PVT LTD is the dominant customer, accounting for 96.8% of this supplier's tracked business. Top customers include:
• BREATHEFREE LANKA PVT LTD — $7.2M across 89 shipments (96.8% of this supplier's total exports)
• BREATHEFREE LANKA PR — $205.3K across 3 shipments (2.8% of this supplier's total exports)
• GENERICAL S.A — $23.3K across 0 shipments (0.3% of this supplier's total exports)
• CAPITAL PHARMACY — $3.7K across 0 shipments (0.1% of this supplier's total exports)
• JDS CO LIMITED — $3.2K across 0 shipments (0.0% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $80.4K is 207% above the market average of $26.2K, consistent with large-order contracts or value-added formulations.
5DR.REDDY'S LABORATORIES LTD
DR.REDDY'S LABORATORIES LTD is the fifth-largest Montelukast exporter from India, with a market share of 2.1% and a total export value of $3.5M across 219 shipments. Their average shipment value of $15.9K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR. REDDYS LABORATORIES, INC — $1.2M across 78 shipments (35.4% of this supplier's total exports)
• DR. REDDYS LABORATORIES, INC — $843.0K across 53 shipments (24.2% of this supplier's total exports)
• DR.REDDY'S LABORATOR — $626.3K across 39 shipments (18.0% of this supplier's total exports)
• DR. REDDYS LABORATORIES, INC — $443.9K across 28 shipments (12.8% of this supplier's total exports)
• MOVIANTO UK LTD, — $332.6K across 21 shipments (9.6% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (219 shipments) at a per-shipment value of $15.9K, indicating a broad distribution network with many smaller, regular orders.
6TORRENT PHARMACEUTICALS LTD
TORRENT PHARMACEUTICALS LTD is the fifth-largest Montelukast exporter from India, with a market share of 1.3% and a total export value of $2.2M across 221 shipments. Their average shipment value of $10.0K is below the market average of $26.2K, reflecting a high-volume, competitive pricing strategy.
TORRENT PHARMACEUTICALS LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• ORION CORPORATION — $676.5K across 68 shipments (30.8% of this supplier's total exports)
• TRINITY PHARMA (PTY) — $633.0K across 64 shipments (28.8% of this supplier's total exports)
• AL FARABI PHARMACY — $378.2K across 38 shipments (17.2% of this supplier's total exports)
• PHARMA DYNAMICS (PTY — $264.4K across 27 shipments (12.0% of this supplier's total exports)
• HEUMANN PHARMA GMBH — $247.7K across 25 shipments (11.3% of this supplier's total exports)
Key Insight: TORRENT PHARMACEUTICALS LTD operates with high shipment frequency (221 shipments) at a per-shipment value of $10.0K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Montelukast Flows
Once Montelukast leaves the manufacturing plants of companies like MACLEODS PHARMACEUTICALS LTD and UNICHEM LABORATORIES LIMITED, it travels to 5 destination markets with a combined import value of $168.3M. United States absorbs the largest share at 58.1% ($97.8M), followed by Philippines (7.9%) and Sri Lanka (5.1%).
In United States — the top destination — named importers include AMERISOURCE HEALTH SERVICES, MACLEODS PHARMA USA ,INC, UNICHEM PHARMACEUTICALS (USA) INC.. In Philippines, key buyers are THE CATHAY DRUG CO. INC, THE CATHAY DRUG CO INC, AJANTA PHARMA PHILIPPINES INC.
This geographic spread reflects Montelukast's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Montelukast Go? Top Importing Countries & Their Buyers
Trade flow of Montelukast exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Montelukast imports from India, with a total trade value of $97.8M across 454 shipments — representing a 58.1% share of all Montelukast exports. The average shipment value of $215.4K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.
Named Montelukast importers in United States: AMERISOURCE HEALTH SERVICES is the largest buyer, accounting for 29.9% ($29.2M) of this market's total imports.
• AMERISOURCE HEALTH SERVICES — $29.2M (29.9% of United States's total)
• MACLEODS PHARMA USA ,INC — $25.3M (25.9% of United States's total)
• UNICHEM PHARMACEUTICALS (USA) INC. — $6.3M (6.5% of United States's total)
Key Insight: United States's per-shipment average of $215.4K (723% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Montelukast imports from India.
2Philippines
Philippines ranks as the second-largest destination for Montelukast imports from India, with a total trade value of $13.3M across 29 shipments — representing a 7.9% share of all Montelukast exports. The average shipment value of $459.1K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Montelukast importers in Philippines: THE CATHAY DRUG CO. INC is the largest buyer, accounting for 31.2% ($4.2M) of this market's total imports.
• THE CATHAY DRUG CO. INC — $4.2M (31.2% of Philippines's total)
• THE CATHAY DRUG CO INC — $2.6M (19.2% of Philippines's total)
• AJANTA PHARMA PHILIPPINES INC — $2.3M (17.6% of Philippines's total)
Key Insight: Philippines's per-shipment average of $459.1K (1654% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Montelukast imports from India.
3Sri Lanka
Sri Lanka ranks as the third-largest destination for Montelukast imports from India, with a total trade value of $8.5M across 67 shipments — representing a 5.1% share of all Montelukast exports. The average shipment value of $127.5K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Montelukast importers in Sri Lanka: BREATHEFREE LANKA PVT LTD is the largest buyer, accounting for 91.3% ($7.8M) of this market's total imports.
• BREATHEFREE LANKA PVT LTD — $7.8M (91.3% of Sri Lanka's total)
Key Insight: Sri Lanka's per-shipment average of $127.5K (387% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Montelukast imports from India.
4United Kingdom
United Kingdom ranks as the fourth-largest destination for Montelukast imports from India, with a total trade value of $8.1M across 115 shipments — representing a 4.8% share of all Montelukast exports. The average shipment value of $70.3K is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Montelukast importers in United Kingdom: ACCORD UK is the largest buyer, accounting for 16.0% ($1.3M) of this market's total imports.
• ACCORD UK — $1.3M (16.0% of United Kingdom's total)
• GLENMARK PHARMACEUTICALS EUROPE LTD — $1.2M (15.3% of United Kingdom's total)
Key Insight: United Kingdom's per-shipment average of $70.3K (169% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United Kingdom is a key market for Montelukast imports from India.
5South Africa
South Africa ranks as the fifth-largest destination for Montelukast imports from India, with a total trade value of $6.7M across 0 shipments — representing a 4.0% share of all Montelukast exports. The average shipment value of $6.7M is above the global average of $26.2K, indicating high-value procurement contracts or branded formulations.
Key Insight: South Africa's per-shipment average of $6.7M (25525% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
South Africa is a key market for Montelukast imports from India.
People Also Ask — Montelukast Supplier & Trade Network
Who are the top suppliers of Montelukast from India?+
Which companies buy Montelukast from Indian manufacturers?+
Where does Montelukast exported from India go?+
What is the market share of the top Montelukast supplier from India?+
What is the average shipment value for Montelukast exports from India?+
Is Montelukast manufactured in India and exported globally?+
Which country imports the most Montelukast from India?+
Who are the buyers of Montelukast in Philippines?+
How concentrated is the Montelukast supplier market in India?+
How do I find verified buyers for Montelukast in specific countries?+
Montelukast Trade Network — Key Takeaways
- 1MACLEODS PHARMACEUTICALS LTD is India's dominant Montelukast exporter with a 36.4% market share and $61.3M in total exports — making it the single most important sourcing entity in this market.
- 2The top 510 suppliers collectively account for 54.2% of all tracked Montelukast exports, with a combined trade value of $168.3M.
- 3United States is the largest destination market, absorbing 58.1% of India's Montelukast exports ($97.8M). Philippines (7.9%) and Sri Lanka (5.1%) follow.
- 4With 6.4K total shipments averaging $26.2K each, the Montelukast export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AMERISOURCE HEALTH SERVICES, MACLEODS PHARMA USA ,INC, UNICHEM PHARMACEUTICALS (USA) INC, UNICHEM PHARMACEUTICALS (USA) INC — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 138 countries
Network value: $168.3M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Montelukast — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Montelukast.
- 2.Flow Mapping: 510 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 6,431 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 138 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,431 Verified Shipments
510 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists